«Pacemaker Arrhythmia

Below is an extended Pacemaker Arrhythmia research listing. Click here to return to the Pacemaker Arrhythmia main in depth entry.

Recent Publications on Pacemaker Arrhythmia:
Implantable cardioverter defibrillator therapy.		24th September, 2005	Pacemaker & Arrhythmia Services, The Heart Group, Inc, Akron, Ohio 44236,
New devices and hybrid therapies and new devices for treatment of atrial fibrillation.		15th July, 2000	The Pacemaker & Arrhythmia Service, Eastern Heart InstituteAtlantic Health
Catheter mapping of spontaneous and induced atrial fibrillation in man.		15th July, 2000	The Pacemaker & Arrhythmia Service, Eastern Heart Institute-Atlantic
Implantable Cardioverter-Defibrillator Implantation in the Electrophysiology Laboratory by Electrophysiologists.		14th April, 2000	Director of Electrophysiology and Pacemaker Arrhythmia Center, 222 Station
Intravenous Procainamide for Predicting the Response of Sustained Ventricular Tachycardia to Type III Antiarrhythmic Drugs.		14th April, 2000	Director of Pacemaker-Arrhythmia Center, Winthrop University Hospital, 259
QT Dispersion N A Simple and Cheap Method for Predicting Ventricular Tachycardia Susceptibility.		14th April, 2000	Director, Pacemaker - Arrhythmia Center, Winthrop University Hospital, 259

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.